Kweli Thompson - 31 Jul 2026 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: EVP & President, Neuroscience
Issuer ticker: MDT
Reported as of: 31 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Aug 2026, 19:59:46 UTC
Prior SEC filing: 26 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Kweli Thompson filed Form 4 for Medtronic plc (MDT) on 04 Aug 2026.

Key facts

This page summarizes Kweli Thompson's Form 4 filing for Medtronic plc (MDT).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Aug 2026, 19:59.

Change

Previous filing in this sequence was filed on 26 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002137804 Primary reporting owner

Thompson Kweli

Relationship: EVP & President, Neuroscience
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -1,739
Change %: -5.8%
Price: $85.39^*
Shares after: 28,467
Date: 31 Jul 2026
Ownership: Direct
Footnotes: F1, F2

MDT transaction

Ordinary Shares

Award

Transaction value
Shares: +6,923
Change %: +24%
Price: $0.000000^*
Shares after: 35,390
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Units

Award

Transaction value
Shares: +17,306
Change %
Price: $0.000000^*
Shares after: 17,306
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 17,306
Exercise price
Footnotes: F4, F5, F6

MDT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +49,167
Change %
Price: $0.000000^*
Shares after: 49,167
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 49,167
Exercise price: $86.68
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Footnote F2

Includes 188 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Footnote F3

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Footnote F4

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F5

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

Footnote F6

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Footnote F7

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.